Ledger.Open graph →
SEC Form D · filed November 3, 2021

Cardurion Pharmaceuticals, Inc

Offering
$128.1M
Sold
$46.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Kenneth Novack · Boston, MADirectorNicholas Downing · Boston, MADirectorJeb Keiper · Boston, MADirectorAmy Schulman · Boston, MADirectorChristopher N. Crow · Wilsonville, ORDirectorKeith Gottesdiener · Boston, MADirectorRobert D. Milks, Jr · Grayson, GADirectorAdam Koppel · Boston, MADirectorBrian H. Schreiber · Washington, Washington, D.C.DirectorJustin M. Scott · Mt. Pleasant, SCExec · DirectorKeith Gottesdiener · Boston, MADirectorMichael Mendelsohn · Boston, MAExec · DirectorDesmond E. Mitchell · Luxembourg, LuxembourgExec · DirectorPeter Lawrence · Boston, MAExec · DirectorConstantine H. Iordanou · Hamilton, BermudaDirectorPeter Lawrence · Boston, MAExec · DirectorDain N. Zaitz · Wilsonville, ORDirectorDalton M. Dale · ST. PETERSBURG, FLDirectorAdam Koppel · Cambridge, MADirectorNicholas Downing · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗